Aller au contenu principal
Accès ouvert déclaré 2025 article

Recurrent angiofibroma: analysis of risk factors and common sites of recurrence

2Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : Égypte. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

OBJECTIVE: To detect risk factors and common anatomical sites for recurrence of juvenile nasopharyngeal angiofibroma (JNA). METHODS: This is a retrospective study, included all male patients who were diagnosed histopathologically with juvenile nasopharyngeal angiofibroma (JNA) and were operated before at Kasr Al-Ainy Hospital, Cairo University in the period between January 2012 and December 2021. Their clinical data were retrieved and analyzed. RESULTS: Among 68 patients included in this study, 26 patients experienced recurrence with total recurrence rate (38.2%). JNA recurrence was significantly associated with primary tumor size (≥ 4 cm), advanced primary tumor stages (stage IIIa, IIIb according to Radkowski classification) and their correlatives of preoperative embolization, perioperative blood transfusion or open surgical approach. Age on presentation, tumor stage, perioperative blood transfusion and tumor size were significant factors affecting the recurrence rate according to cox regression univariate analysis, while on multivariate analysis the only significant independent predictors of JNA recurrence were age on presentation and tumor size. 61.53% of recurrent cases were discovered accidently through their regular postoperative follow up examination and/or imaging and were asymptomatic upon diagnosis of recurrence. Moreover, patients with early tumor stage or didn't undergo preoperative embolization or had a primary tumor size < 4 cm had significantly longer recurrence interval than those with advanced tumor stage or underwent preoperative embolization or had a primary tumor size ≥ 4 cm. Pterygoid process (92.3%) was significantly the commonest to be invaded by recurrent/residual tumor, followed by nasopharynx (84.6%) and sphenoid sinus (76.9%). CONCLUSION: JNA recurrence is significantly associated with primary tumor size, primary tumor stage and their correlatives of preoperative embolization, perioperative blood transfusion or open surgical approach, but age on presentation and primary tumor size were the only independent predictors of tumor recurrence. Meticulous surgical attention should be paid for pterygoid process in order to decrease residual/recurrence incidence.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Recurrent angiofibroma: analysis of risk factors and common sites of recurrence
Date Crossref
03/06/2025
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Cairo University Cairo University, Égypte (code pays fourni par la source)
    Université ou école supérieure

Cairo University (Cairo University, Égypte). Pays d’affiliation : Égypte.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Head and Neck Surgical OncologySinusitis and nasal conditionsTeratomas and Epidermoid Cysts

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.